MEDGENICS INC - COM NEW (MDGN)

CUSIP: 58436Q203

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM NEW
Total 13F shares
13,665,664
Share change
+106,557
Total reported value
$60,162,000
Price per share
$4.40
Number of holders
55
Value change
-$452,740
Number of buys
18
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 58436Q203?
CUSIP 58436Q203 identifies MDGN - MEDGENICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDGENICS INC - COM NEW (MDGN) as of Q1 2016

As of 31 Mar 2016, MEDGENICS INC - COM NEW (MDGN) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,665,664 shares. The largest 10 holders included Broadfin Capital, LLC, JENNISON ASSOCIATES LLC, Opaleye Management Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., QVT Financial LP, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, BlackRock Institutional Trust Company, N.A., and BlackRock Fund Advisors. This page lists 55 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.